News Releases
- July 10, 2008
Entelos Announces U.S. Patent for Gene Expression Test for Liver Toxicity Screening
- July 10, 2008
Entelos Announces DrugMatrix Perpetual License Agreement with Lilly
- July 10, 2008
Trading Statement
- May 20, 2008
Option Grants
- May 20, 2008
Result of AGM
- April 30, 2008
Entelos Announces Agreement with Lilly
- April 30, 2008
2007 Annual Report and Accounts & AGM Notification
- April 28, 2008
Entelos Joins Consortium funded by Pfizer to Identify New Targets for Diabetes and Obesity
- April 23, 2008
Entelos Announces New Research Contract
- April 16, 2008
Preliminary Results for the Year Ended 31 December 2007
- April 16, 2008
Entelos to Partner with Unilever to Develop Next Generation Physiolab Platform
- April 8, 2008
American Diabetes Association and Entelos Broaden Access to Testing with “Virtual Mice”
- April 3, 2008
Entelos Announces U.S. Patent for its Diabetes Model
- April 1, 2008
Notice of Preliminary Results for the Twelve Months Ended 31 December 2007
- March 25, 2008
Appointment of NOMAD and Broker
- February 21, 2008
Entelos Announces Agreement with PDL Biopharma
- February 5, 2008
Trading Statement
- January 21, 2008
Entelos Announces Agreement with UCB Pharma in Rheumatoid Arthritis
- December 28, 2007
Entelos executes $6,500,000 debt facility with Imperium
- December 19, 2007
Entelos Signs Agreement with Johnson & Johnson Pharmaceutical Research and Development, LLC to Study Therapies for Diabetes
|
